Shionogi Inc. (U.S.)

Shionogi Inc. (U.S.) is a pharmaceutical company committed to improving patient lives by developing innovative treatments for challenging diseases. Since its establishment in 1878, Shionogi has focused on addressing global health issues such as antimicrobial resistance and COVID-19, with a strong emphasis on research and development of novel antibiotics and antiviral medications. The company prioritizes scientific excellence and collaboration with various partners to advance healthcare solutions.